Defining the identity of human adipose-derived mesenchymal stem cells
2014; NRC Research Press; Volume: 93; Issue: 1 Linguagem: Inglês
10.1139/bcb-2014-0094
ISSN1208-6002
AutoresElisa Montelatici, Barbara Baluce, Enrico Ragni, Cristiana Lavazza, Valentina Parazzi, Riccardo F. Mazzola, Giovanna Cantarella, Massimiliano Brambilla, Rosaria Giordano, Lorenza Lazzari,
Tópico(s)Tissue Engineering and Regenerative Medicine
ResumoAdipose-derived mesenchymal stem cells (ADMSCs) are an ideal population for regenerative medical application. Both the isolation procedure and the culturing conditions are crucial steps, since low yield can limit further cell therapies, especially when minimal adipose tissue harvests are available for cell expansion. To date, a standardized procedure encompassing both isolation sites and expansion methods is missing, thus making the choice of the most appropriate conditions for the preparation of ADMSCs controversial, especially in view of the different applications needed. In this study, we compared the effects of three different commercial media (DMEM, aMEM, and EGM2), routinely used for ADMSCs expansion, and two supplements, FBS and human platelet lysate, recently proven to be an effective alternative to prevent xenogeneic antibody transfer and immune alloresponse in the host. Notably, all the conditions resulted in being safe for ADMSCs isolation and expansion with platelet lysate supplementation giving the highest isolation and proliferation rates, together with a commitment for osteogenic lineage. Then, we proved that the high ADMSC hematopoietic supportive potential is performed through a constant and abundant secretion of both GCSF and SCF. In conclusion, this study further expands the knowledge on ADMSCs, defining their identity definition and offers potential options for in vitro protocols for clinical production, especially related to HSC expansion without use of exogenous cytokines or genetic modifications.
Referência(s)